Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the international metastatic renal-cell carcinoma database consortium prognostic model (IMRCC). The SPAZO study (SOGUG)

Vázquez Estévez, Sergio

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/6020

ISSN: 0959-8049

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

EUROPEAN JOURNAL OF CANCER

Type of content

Publicación de congreso